Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
CANC
51
HOLDINGS
67%
ALSO IN IBB
IBB
249
HOLDINGS
16%
ALSO IN CANC
SECTOR DRIFT (CANC minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.5% | 7.7% | 2.5% |
|
BEIGENE LTD. SPONSORED ADR | 2.5% | 1.8% | 1.8% |
|
AMGEN INC | 1.8% | 7.3% | 1.8% |
 |
ARGENX SE ADR | 1.6% | 3.3% | 1.6% |
 |
GENMAB A/S SPONSORED ADR | 4.1% | 1.3% | 1.3% |
CANC Overweight Relative to IBB
|
REVOLUTION MEDICINES, INC. | 6.2% |
|
ELI LILLY & CO | 5.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.2% |
|
NOVARTIS AG | 4.2% |
 |
ASTRAZENECA PLC | 4.1% |
|
ARCELLX, INC. | 3.4% |
|
NUVALENT, INC. CLASS A | 3.3% |
|
BRIDGEBIO PHARMA, INC. | 3.1% |
|
GENMAB A/S SPONSORED ADR | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% |
CANC Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -7.7% |
|
AMGEN INC | -5.5% |
|
ALNYLAM PHARMACEUTICALS INC | -5.4% |
|
GILEAD SCIENCES INC | -5.2% |
|
REGENERON PHARMACEUTICALS | -4.2% |
|
IQVIA HOLDINGS INC | -3.5% |
|
INSMED INC | -3.1% |
|
METTLER-TOLEDO INTERNATIONAL | -2.7% |
|
NATERA INC | -2.4% |
|
BIOGEN IDEC INC | -2.0% |